These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32569093)

  • 1. Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic pain.
    Moutal A; Cai S; Yu J; Stratton HJ; Chefdeville A; Gomez K; Ran D; Madura CL; Boinon L; Soto M; Zhou Y; Shan Z; Chew LA; Rodgers KE; Khanna R
    Pain; 2020 Nov; 161(11):2629-2651. PubMed ID: 32569093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-SUMOylated CRMP2 decreases Na
    Gomez K; Ran D; Madura CL; Moutal A; Khanna R
    Mol Brain; 2021 Jan; 14(1):20. PubMed ID: 33478555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
    François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
    Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
    Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
    J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels.
    François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R
    Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.
    Dustrude ET; Perez-Miller S; François-Moutal L; Moutal A; Khanna M; Khanna R
    Channels (Austin); 2017 Jul; 11(4):316-328. PubMed ID: 28277940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.
    Dustrude ET; Moutal A; Yang X; Wang Y; Khanna M; Khanna R
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8443-E8452. PubMed ID: 27940916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α mediated upregulation of Na
    de Macedo FHP; Aires RD; Fonseca EG; Ferreira RCM; Machado DPD; Chen L; Zhang FX; Souza IA; Lemos VS; Romero TRL; Moutal A; Khanna R; Zamponi GW; Cruz JS
    Mol Brain; 2019 Dec; 12(1):117. PubMed ID: 31888677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell specific regulation of NaV1.7 activity and trafficking in rat nodose ganglia neurons.
    Loya-López SI; Duran P; Ran D; Calderon-Rivera A; Gomez K; Moutal A; Khanna R
    Neurobiol Pain; 2022; 12():100109. PubMed ID: 36531612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents.
    Cai S; Moutal A; Yu J; Chew LA; Isensee J; Chawla R; Gomez K; Luo S; Zhou Y; Chefdeville A; Madura C; Perez-Miller S; Bellampalli SS; Dorame A; Scott DD; François-Moutal L; Shan Z; Woodward T; Gokhale V; Hohmann AG; Vanderah TW; Patek M; Khanna M; Hucho T; Khanna R
    Sci Transl Med; 2021 Nov; 13(619):eabh1314. PubMed ID: 34757807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.
    Ju W; Li Q; Wilson SM; Brittain JM; Meroueh L; Khanna R
    Channels (Austin); 2013; 7(3):153-9. PubMed ID: 23510938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and targeting of a unique Na
    Gomez K; Stratton HJ; Duran P; Loya S; Tang C; Calderon-Rivera A; François-Moutal L; Khanna M; Madura CL; Luo S; McKiver B; Choi E; Ran D; Boinon L; Perez-Miller S; Damaj MI; Moutal A; Khanna R
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2217800120. PubMed ID: 37498871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain.
    Braden K; Stratton HJ; Salvemini D; Khanna R
    Neurobiol Pain; 2022; 11():100082. PubMed ID: 35024498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal CRMP2-Ubc9 inhibitor regulates Na V 1.7 to alleviate trigeminal neuropathic pain.
    Loya-Lopez SI; Allen HN; Duran P; Calderon-Rivera A; Gomez K; Kumar U; Shields R; Zeng R; Dwivedi A; Saurabh S; Korczeniewska OA; Khanna R
    Pain; 2024 Mar; 165(3):573-588. PubMed ID: 37751532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping protein interactions of sodium channel Na
    Kanellopoulos AH; Koenig J; Huang H; Pyrski M; Millet Q; Lolignier S; Morohashi T; Gossage SJ; Jay M; Linley JE; Baskozos G; Kessler BM; Cox JJ; Dolphin AC; Zufall F; Wood JN; Zhao J
    EMBO J; 2018 Feb; 37(3):427-445. PubMed ID: 29335280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
    Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
    Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining the Na
    Chew LA; Bellampalli SS; Dustrude ET; Khanna R
    Biochem Pharmacol; 2019 May; 163():9-20. PubMed ID: 30699328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats.
    Li J; Stratton HJ; Lorca SA; Grace PM; Khanna R
    Channels (Austin); 2022 Dec; 16(1):1-8. PubMed ID: 34983286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRMP2-Neurofibromin Interface Drives NF1-related Pain.
    Moutal A; Sun L; Yang X; Li W; Cai S; Luo S; Khanna R
    Neuroscience; 2018 Jun; 381():79-90. PubMed ID: 29655575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.
    Gomez K; Allen HN; Duran P; Loya-Lopez S; Calderon-Rivera A; Moutal A; Tang C; Nelson TS; Perez-Miller S; Khanna R
    Pain; 2024 Apr; 165(4):866-883. PubMed ID: 37862053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.